Dr. Jose Iglesias is Director of Apex Oncology, a clinical development consultancy focused in the areas of solid tumor oncology, and he is consulting Chief Medical Officer to Panavance Therapeutics. Dr. Iglesias brings 30 years of global experience in the pharmaceutical industry to Panavance, including large pharma and biotech. He has proven leadership in designing and leading all phases of oncology clinical trials, including large Phase 3 registration studies with over 2,000 patients. Since 2019 Dr. Iglesias has been an independent oncology consultant focused in the areas of solid tumor oncology, immuno-oncology and translational medicine, in early phase to mid-phase clinical development. Earlier in his career he held roles of increasing responsibility at Abraxix BioScience including Vice President of Global Clinical Development and Chief Medical Officer where he was responsible for worldwide development of Abraxane and all other pipeline molecules. Dr. Iglesias also served as Vice President of Clinical Development at Celgene where he was responsible for Phase 3 development of Abraxane for pancreatic, lung and metastatic breast cancer. He has also held senior level medical roles at Bionomics, Biothera, and Apobiologix where he oversaw the global clinical development of its oncology biosimilars program. He is widely conversant with regulatory bodies worldwide, government reimbursement agencies, oncology cooperatives and patient advocacy groups. He has extensively published in the oncology literature with over 8,000 citations. Dr. Iglesias graduated from medical school in 1986, spent 2 years as a fellow at Duke University and 2 years in oncology clinics and in private oncology and hematology practice prior to joining the pharmaceutical industry.